Terameprocol in Treating Patients With Recurrent High Grade Glioma
Clinical trial NCT02575794 · COMPLETED
Trial details
- NCT number
- NCT02575794
- Sponsor
- Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2018-05-03
- Primary completion
- 2023-09-30
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.